News: New Fluid Monitor release: all retreatment parameters at a glance

News: RetInSight and Heidelberg Engineering provide seamless access to the recently MDR CE-certified RetInSight Fluid Monitor

RetInSight – A digital health company developing transformational retinal AI solutions to improve patient outcomes, increase clinical efficiency and reduce healthcare costs

We empower eye care providers and professionals, academic institutions, and the eye care industry to reimagine clinical care with our extensive artificial intelligence solutions. RetInSight helps its partners leverage data to provide novel insights in unmet diagnostic needs associated with diseases that manifest in the retina.

AI to Eye


Bringing together the most advanced technologies in computer and state-of-the-art medical sciences, we are set on shaping the future of digital precision medicine.


Fluid Monitor: AI-based, micro-level precision for detection and quantification of intra- and sub-retinal fluid biomarkers. Preclinical diagnosis, prognosis, and therapy guidance of AMD, DME and RVO with precision beyond expert human examiners.

  • Patented
  • MDR compliant at launch, CE Mark on track
  • Development according to EU guidelines for trustworthy AI development
  • State-of-the-art deep learning methods using one of the most comprehensive, rapidly growing, and quality-controlled data sets

In cooperation with academic institutions, pharmaceutical companies and supported by public funds we are continuously developing new algorithms for unmet diagnostic needs, with a focus on Therapeutic Monitoring and Diagnostic Screening. Please contact us if you are interested at


We develop and deliver our services on a comprehensive and flexible AI platform.

We offer cloud-based AI modules tailored to your needs: Stand-alone, device integration, and/or PACS integration.

We offer cloud-based AI modules tailored to your needs: Stand-alone, device integration, and/or PACS integration.


We are one team with one goal:
Bringing AI to the Eye

As a spin-off of the Medical University of Vienna, we build on more than 8 years of global academic leadership in AI-based retinal image analysis and 15 years of tele-ophthalmology at the largest ophthalmological hospital in Europe, in partnership with more than 800 clinical sites over four continents. Our interdisciplinary team stands for competence, experience and innovation to bring AI to the eye and beyond.


Passion for early detection and monitoring, accurate diagnosis and efficient care drives what we do every day. We strive to provide point-of-care testing of patients with eye or systemic disease based on objective, reliable and personalized data analytics.

Whether you are an OCT manufacturer, pharmaceutical company, reading center, PACS or EMR provider, software company, healthcare provider, research organization or other stakeholder who shares our vision and is interested in our AI solutions, please contact us at